Previous studies have demonstrated that GLP-1R agonist inhibits NOX4-mediated ROS production in high-glucose cultured endothelial cells or angiotensin II-induced cardiac hypertrophy [37,38]. This evidence concerns the gene GLP1R and cardiac hypertrophy.